Regulation of inner retinal vascularization by the novel lactate receptor, GPR81.
Regulation of inner retinal vascularization by the novel lactate receptor, GPR81.
批准号:
291804
负责人:
Chemtob Sylvain
金额:
$45.76万
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2013
资助国家:
加拿大
项目状态:
已结题
起止时间:
2013-09-01 至 2018-09-01
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Ischemic retinopathies such as those associated with diabetes and prematurity, are a major cause of visual impairment in adults and children. Aberrant formation of new vessels outside the retina per se, represents the most dramatic outcome of ischemic ret
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Canada Research Chair - Tier 1
-
批准号:375897
-
项目类别:
-
资助金额:$101.99万
-
财政年份:2017
-
负责人:Chemtob Sylvain
-
依托单位:
Choroidopathies in retinopathies: pathogenesis and therapeutic discoveries
-
批准号:355167
-
项目类别:Operating Grants
-
资助金额:$165.1万
-
财政年份:2016
-
负责人:Chemtob Sylvain
-
依托单位:
Oxygen and brain injury in the newborn: unprecedented role for fatty acid receptors and characterization of potential therapeutics
-
批准号:255634
-
项目类别:Operating Grants
-
资助金额:$41.76万
-
财政年份:2012
-
负责人:Chemtob Sylvain
-
依托单位:
CANADA RESEARCH CHAIRHOLDER – TIER 1 / TITULAIRE DE CHAIRE DE RECHERCHE DU CANADA – NIVEAU 1
-
批准号:228297
-
项目类别:
-
资助金额:$101.99万
-
财政年份:2010
-
负责人:Chemtob Sylvain
-
依托单位:
IL-1 Allosteramers to treat diabetes and its complications
-
批准号:205221
-
项目类别:Operating Grants
-
资助金额:$21.86万
-
财政年份:2010
-
负责人:Chemtob Sylvain
-
依托单位:
Mechanisms of Retinopathy of Prematurity: Role of PAR-2 in restoration of retinal microvascular bed
-
批准号:172044
-
项目类别:Operating Grants
-
资助金额:$44.62万
-
财政年份:2008
-
负责人:Chemtob Sylvain
-
依托单位:
海外基金